We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: FDA Raps Five Firms for Testing, Other Violations
Warning Letter Roundup: FDA Raps Five Firms for Testing, Other Violations
Five drugmakers drew warnings from the FDA for serious quality failures, including “superpotent” products, inadequate stability data and a lack of validation testing.